Public trust in scientists remains high, but nearly half of people say they don’t understand what scientists are saying. Based on insights from the 2024 Edelman Trust Barometer, this post explores how biotech companies can bridge the communication gap with clear, trustworthy messaging that supports innovation adoption and builds long-term credibility.

Let's be honest, you didn't start your biotech company to become a marketing expert. Yet here you are. Juggling R&D, fundraising, business development, and somehow fitting marketing into whatever time remains (which is usually none).